Recursion

News

Change at the top of Recursion as co-founder leaves CEO role

After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.

News

Thomas Appio, Bausch Health's chief executive

Bausch Health hit as Xifaxan successor flunks trials

A hole has been blown in Bausch Health's late-stage pipeline, after a follow-up to its top-selling drug product Xifaxan failed two phase 3 trials.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Change at the top of Recursion as co-founder leaves CEO role

AI medicines are coming: Building the foundations for discov...

The AI drug discovery race: Who’s leading the charge?

Bausch Health hit as Xifaxan successor flunks trials

How to meet your physicians where they are online

Editor's Picks